New Israeli Inventions: Online Retinal Test and Implantable Miniature Telescope

Several new vision inventions are coming out of Israel. An innovative retinal diagnostic test can be completed entirely online. Also, an implantable miniature telescope restores vision to those with partial retinal damage. This technology is available in the United States today or within the next year.

At-Home Retinal Diagnostic Test

AEYE Health is a privately-held online health company headquartered in Tel Aviv and New York that provides online retinal diagnosis. Formed in 2016, AEYE’s team of seasoned entrepreneurs invented an AI system with a database of 100,000 images of the retina and its inner structures, the basis of their diagnostic tool. According to their website, all it takes is two easy steps to obtain results. Their aim is to become by 2020 the first FDA-approved retinal screening solution for home use.

Retinal imaging, a simple procedure, can detect a variety of medical conditions that prevent blindness and can save lives, i.e., diabetes/prediabetes, diabetic retinopathy, glaucoma, and age-related macular degeneration. Fewer than 25% of the 70 million high-risk individuals in the U.S. have this annual screening performed. The interpretation is expensive and impractical. AEYE Health, through their team of experts, found an easy and practical solution with their AI-based retinal diagnostic website.

Implantable Miniature Telescope

implantable telescopeVisionCare, Inc.’s main product, The Implantable Miniature Telescope, is the only FDA-approved surgical implantable medical device. Smaller than a pea, this telescopic implant improves vision and quality of life for patients 55 years and older with stable severe to profound vision impairment associated with end-stage AMD. The treatment program is available in the U.S. (Medicare-eligible/VA/Federal Government Schedule), Canada, Europe, Australia, Israel, and New Zealand. 

Invented by Dr. Isaac Lipshitz, the implant uses micro-optical technology to magnify images normally seen straight ahead. They are projected onto the retina not affected by the disease so that patients can see or discern the targeted objects. A new smaller incision telescope could be available in Europe during 2020.

VisionCare, Inc., through current clinical trials, is investigating the safety and effectiveness of exchanging a previously implanted intraocular lens with the implant. The telescope implant is contraindicated in patients with previous intraocular or corneal surgery in the operative eye, including cataract surgery.